Diagnostic Evidence Co-operative Newcastle

The Diagnostic Evidence Co-operative Newcastle is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.

The NIHR DEC Newcastle facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us

News & Developments

NEW!! PhD Studentship in Diagnostic Test Evaluation Methodology - Evaluations of diagnostic tests in the presence of an imperfect reference standard and the health economic considerations. 

This an exciting opportunity for a PhD student to the forefront of diagnostic test methodology research, and interact closely with the DEC Newcastle.  You will explore how to improve estimates of diagnostic accuracy and removal of bias.  You will then use value of information (VOI) analysis to estimate if the benefits of that research outweighs the time and cost required to carry out that research of that research. Click here for more detail and how to apply.

£15m Innovation in health and life sciences round 1 - Innovate UK

The aim of this competition is to stimulate innovation in Health and Life Sciences (H&LS). Click here for details.  Deadline 16 November. Themes include:
Precision medicine:
  • paediatrics and child health
  • stratification in primary care and the community, including direct-to-consumer products
  • companion diagnostics
  • antimicrobial resistance
13th Call for NIHR i4i Product Development Awards 

NIHR i4i Product Development awards support research and development of medical devices, active implantable devices and in vitro diagnostic devices in any area of existing or emerging clinical need. These awards comprise both early and late stages of research and development, including the clinical development of laboratory-validated technologies or interventions. Click here for details

£15m Stratified Medicine Initiative - call for proposals for disease-focused partnerships to stratify for patient benefit

This call aims to support consortia to address disease areas where there is a strong case for scientific advancement and major unmet clinical need. The call will maintain stratification by response to treatment but broaden the scope to include stratification by risk, diagnosis and/or prognosis. Up to £15m to fund consortia up to 5 years in duration will be available. Click here for details of the competition and how to apply. 

Postgraduate on-line learning programme in:
Clinical Health Sciences Molecular Pathology
MRC/EPSRC Newcastle Molecular Pathology Node, in conjunction with the NIHR DEC, is providing a range of on-line learning modules to enable you to gain expertise in molecular pathology and diagnostic evaluation and its relation to stratified and personalised medicine. See the flyer for more details. 

News from the BBC